GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nonrelated Party | - | - | - | - | - | 3,564 | 75 | 19 | 3,324 | 3,525 | 3 | 3,370 | |||||
Related Party | - | - | - | - | - | 3,564 | 75 | 19 | 3,324 | 3,525 | 3 | 3,370 | |||||
Accounts And Other Receivables Net Current | 3,786 | 3,955 | 3,734 | 3,562 | 3,572 | 3,566 | - | - | - | - | - | - | |||||
Inventory Net | 2,353 | 2,234 | 2,304 | 2,283 | 2,158 | 1,939 | 2,124 | 2,023 | 1,989 | 1,960 | 2,128 | 2,264 | |||||
Other Assets Current | 842 | 726 | 702 | 638 | 601 | 532 | 476 | 437 | 517 | 389 | 484 | 596 | |||||
Assets Current | 10,426 | 12,501 | 11,893 | 11,308 | 9,735 | 9,901 | 10,638 | 8,806 | 9,373 | 9,410 | 9,468 | 9,240 | |||||
Goodwill | 15,060 | 13,489 | 13,441 | 13,417 | 13,373 | 13,136 | 13,138 | 13,116 | 12,927 | 12,936 | 12,914 | 12,929 | |||||
Intangible Assets Net Excluding Goodwill | 1,908 | 1,130 | 1,163 | 1,220 | 1,238 | 1,078 | 1,132 | 1,195 | 1,174 | 1,253 | 1,332 | 1,423 | |||||
Deferred Income Tax Assets Net | 4,383 | 4,491 | 4,468 | 4,517 | 4,462 | 4,474 | 4,309 | 4,365 | 4,413 | 4,474 | 4,277 | 4,349 | |||||
Other Assets Noncurrent | 2,254 | 2,205 | 2,152 | 2,076 | 1,926 | 1,950 | 2,098 | 1,913 | 1,878 | 1,881 | 2,036 | 2,013 | |||||
Assets | 37,125 | 36,906 | 36,127 | 35,500 | 33,586 | 33,089 | 33,855 | 31,852 | 32,208 | 32,454 | 32,382 | 32,311 | |||||
Short Term Borrowings | 7 | 508 | 2,005 | 2,005 | 2,002 | 1,502 | 1,007 | 1,007 | 1,008 | 1,006 | 7 | 5 | |||||
Accounts Payable Current | 3,410 | 3,250 | 2,987 | 2,975 | 3,152 | 3,035 | 2,911 | 2,824 | 2,931 | 2,947 | 2,774 | 2,835 | |||||
Contract With Customer Liability Current | 2,153 | 2,095 | 2,002 | 1,979 | 1,889 | 1,943 | 1,915 | 1,876 | 1,879 | 1,918 | 1,927 | 2,003 | |||||
Employee Related Liabilities Current | 1,418 | 1,666 | 1,542 | 1,364 | 1,343 | 1,521 | 1,422 | 1,235 | - | 1,518 | - | - | |||||
Other Liabilities Current | 1,542 | 1,587 | 1,536 | 1,426 | 1,583 | 1,552 | - | - | - | - | - | - | |||||
Liabilities Current | 8,529 | 9,105 | 10,073 | 9,748 | 9,969 | 9,553 | 8,670 | 8,318 | 8,859 | 8,981 | 7,565 | 7,581 | |||||
Long Term Debt Noncurrent | 10,127 | 9,495 | 8,277 | 8,270 | 6,757 | 7,449 | 9,306 | 8,233 | 8,247 | 8,436 | 10,253 | 10,233 | |||||
Pension And Other Postretirement Defined Benefit P… | 5,300 | 5,453 | 5,287 | 5,351 | 5,443 | 5,583 | 5,388 | 5,455 | 5,625 | 5,782 | 5,373 | 5,167 | |||||
Deferred Income Tax Liabilities Net | 256 | 193 | 171 | 173 | 159 | 56 | 59 | 55 | 68 | 68 | 62 | 81 | |||||
Other Liabilities Noncurrent | 2,015 | 2,061 | 2,100 | 2,005 | 1,840 | 1,796 | 1,920 | 1,796 | 1,811 | 1,877 | 1,826 | 1,926 | |||||
Liabilities | 26,227 | 26,307 | 25,907 | 25,548 | 24,168 | 24,437 | 25,343 | 23,858 | 24,609 | 25,144 | 25,079 | 24,988 | |||||
Redeemable Noncontrolling Interest Equity Carrying… | 218 | 209 | 204 | 220 | 211 | 188 | 177 | 177 | 177 | 165 | 161 | 209 | |||||
Common Stock Value | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Treasury Stock Common Value | -325 | -225 | -225 | -125 | -25 | -25 | -25 | - | - | 0 | - | - | |||||
Additional Paid In Capital | 6,733 | 6,707 | 6,661 | 6,628 | 6,597 | 6,583 | 6,551 | 6,540 | 6,504 | 6,493 | 6,469 | 6,451 | |||||
Retained Earnings Accumulated Deficit | 5,654 | 5,281 | 4,709 | 4,295 | 3,810 | 3,262 | 2,558 | 2,101 | 1,687 | 1,326 | 937 | 576 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1,398 | -1,388 | -1,156 | -1,090 | -1,199 | -1,379 | -771 | -845 | -787 | -691 | -280 | 70 | |||||
Stockholders Equity | 10,668 | 10,390 | 9,993 | 9,733 | 9,187 | 8,464 | 8,335 | 7,817 | 7,423 | 7,133 | 7,142 | 7,102 | |||||
Minority Interest | 12 | 11 | 23 | 21 | 20 | 18 | 18 | 16 | 14 | 12 | 11 | 12 | |||||
Liabilities And Stockholders Equity | 37,125 | 36,906 | 36,127 | 35,500 | 33,586 | 33,089 | 33,855 | 31,852 | 32,208 | 32,454 | 32,382 | 32,311 | |||||
Allowance For Doubtful Accounts Receivable Current | 100 | 103 | 108 | 107 | 106 | 103 | 104 | 103 | 102 | 98 | 91 | 92 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | |||||
Common Stock Shares Issued | 459 | 459 | 459 | 458 | 458 | 457 | 457 | 457 | 456 | 455 | 455 | 455 | |||||
Shares Outstanding | - | - | - | - | - | - | - | 457 | 456 | 455 | 455 | 455 | |||||
Treasury Stock Common Shares | 5 | 3 | 3 | 2 | 0 | 0 | 0 | - | - | 0 | - | - |
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 7.98% | 3.54% | - | - | - | - | - | - | - | - | - | - |
| 2025 | -1.66% | 1.35% | 8.01% | 5.00% | 4.56% | 3.36% | -1.20% | 7.12% | 5.69% | 1.98% | -16.22% | -16.66% |
| 2024 | 4.74% | 3.84% | 5.55% | 0.18% | 6.68% | 7.96% | -5.46% | -9.51% | -2.78% | -7.38% | -35.27% | -24.51% |
| 2023 | - | - | - | -14.77% | -17.18% | -16.32% | 10.73% | 16.54% | 11.37% | 13.13% | 10.92% | 5.26% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.22 | 1.37 | 1.18 | 1.16 | 0.98 | 1.04 | 1.23 | 1.06 | 1.06 | 1.05 | 1.25 | 1.22 | |||||
| Quick Ratio | 0.95 | 1.13 | 0.95 | 0.93 | 0.76 | 0.83 | 0.98 | 0.82 | 0.83 | 0.83 | 0.97 | 0.92 | |||||
| Working Capital | 1.90B | 3.40B | 1.82B | 1.56B | -234.00M | 348.00M | 1.97B | 488.00M | 514.00M | 429.00M | 1.90B | 1.66B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 2.46 | 2.53 | 2.59 | 2.62 | 2.63 | 2.89 | 3.04 | 3.05 | 3.32 | 3.52 | 3.51 | 3.52 | |||||
| Interest Coverage TTM | 6.22 | 6.28 | 6.02 | 5.82 | 5.52 | 5.21 | 4.89 | 4.70 | 4.58 | 4.49 | 4.25 | - | |||||
| Debt Ratio | 0.71 | 0.71 | 0.72 | 0.72 | 0.72 | 0.74 | 0.75 | 0.75 | 0.76 | 0.77 | 0.77 | 0.77 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.59 | 0.59 | 0.58 | 0.59 | 0.60 | 0.60 | 0.59 | 0.61 | 0.60 | 0.60 | 0.44 | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 4.17 | 4.55 | 4.90 | 4.90 | 4.78 | 4.34 | 3.24 | 3.03 | 3.03 | 3.02 | 2.60 | - | |||||
| Free Cash Flow Per Share TTM | 4.09 | 4.05 | 3.82 | 4.09 | 3.67 | 4.07 | 4.37 | 3.54 | 3.65 | 3.77 | 1.67 | - | |||||
| Dividend Per Share TTM | 0.14 | 0.14 | 0.14 | 0.13 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.09 | 0.06 | - | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 39.15% | 39.99% | 40.81% | 41.56% | 42.00% | 41.71% | 41.34% | 40.96% | 40.69% | 40.52% | - | - | |||||
| Operating Profit Margin TTM | 12.63% | 13.40% | 13.52% | 13.82% | 13.71% | 13.34% | 12.85% | 12.57% | 12.39% | 12.45% | 12.17% | - | |||||
| Net Profit Margin TTM | 9.09% | 10.10% | 11.05% | 11.24% | 11.08% | 10.13% | 7.60% | 7.13% | 7.13% | 7.08% | 8.30% | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 5.96% | 4.84% | 3.52% | 2.31% | 1.56% | 0.61% | 36.33% | - | - | - | - | - | |||||
| Net Income Growth (1Y) | -13.04% | 4.57% | 50.50% | 61.21% | 57.77% | 43.90% | 24.85% | - | - | - | - | - | |||||
| EPS Growth (1Y) | -12.85% | 4.57% | 50.83% | 61.21% | 57.42% | 43.58% | 24.31% | - | - | - | - | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 17.01 | 17.93 | 15.28 | 15.06 | 16.78 | 17.84 | 28.75 | 25.49 | 29.71 | 25.30 | 25.87 | - | |||||
| P/B TTM | 3.04 | 3.60 | 3.42 | 3.47 | 4.01 | 4.20 | 5.13 | 4.54 | 5.56 | 4.90 | 4.31 | 5.18 | |||||
| P/S TTM | 1.55 | 1.81 | 1.69 | 1.69 | 1.86 | 1.81 | 2.19 | 1.82 | 2.12 | 1.79 | 2.15 | - | |||||
| Market Cap | 32.44B | 37.37B | 34.20B | 33.79B | 36.80B | 35.55B | 42.76B | 35.49B | 41.30B | 35.03B | 30.82B | 36.78B | |||||
| Enterprise Value | 40.29B | 42.86B | 40.45B | 40.30B | 43.08B | 41.61B | 49.50B | 42.71B | 47.99B | 41.97B | 38.66B | 45.07B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 1.86B | 1.85B | 1.74B | 1.87B | 1.68B | 1.85B | 2.00B | 1.62B | 1.66B | 1.71B | 758.00M | - | |||||
| Net Debt | 7.85B | 5.49B | 6.25B | 6.51B | 6.28B | 6.06B | 6.74B | 7.22B | 6.69B | 6.94B | 7.84B | 8.29B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
GE HealthCare Technologies Inc. (GEHC) — SEC Financial Statements & Analysis
GE HealthCare Technologies Inc. (GEHC) is a x-ray apparatus & tubes & related irradiation apparatus company, incorporated in DE. GE HealthCare Technologies Inc. trades on GEHC: Nasdaq as: GEHC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), GE HealthCare Technologies Inc. reported a 5.96% year-over-year revenue growth, a Gross Profit Margin of 39.15% (TTM), a Debt-to-Equity ratio of 2.46x, a Price-to-Sales (P/S) ratio of 1.55x (TTM), a Price-to-Book (P/B) ratio of 3.04 (TTM), at a market cap of $32.44B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 5.96%
- Gross Profit Margin TTM
- 39.15%
- Debt To Equity
- 2.46x
- P/S TTM
- 1.55x
- P/B TTM
- 3.04
- Market Cap
- $32.44B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is GE HealthCare Technologies Inc. in?
GE HealthCare Technologies Inc. (GEHC) operates in the X-Ray Apparatus & Tubes & Related Irradiation Apparatus industry.
What is GEHC's market cap?
GE HealthCare Technologies Inc. (GEHC) has a market capitalization of $32.44B as of 2026-03-31.
What is GEHC's P/E ratio?
GE HealthCare Technologies Inc. (GEHC)'s trailing twelve month P/E ratio is 17.01x as of 2026-03-31.
What exchange does GEHC trade on?
GE HealthCare Technologies Inc. (GEHC) trades on the GEHC: Nasdaq.
Where is GE HealthCare Technologies Inc. incorporated?
GE HealthCare Technologies Inc. is incorporated in DE.